Quarterly Results

2021

  • Earnings Release
  • AnPac Bio 2021 First Half Revenue Up 128.5% with Non-GAAP Loss Reduced by 18.3%

    • Earnings Release

    AnPac Bio Reports Strong First Quarter in 2021, with 137.2% Increase in Revenue and Record Number of Commercial Tests Completed

    2020

    • Earnings Release

    AnPac Bio Reports Fiscal Year 2020 Annual Financial Results (89.1% Increase in Revenue and 20.7% Decrease in Net Loss)

    • Earnings Release

    AnPac Bio Reports First Six Months of 2020 Financial Results

    ©2021 Anpac Bio-Medical Science Co., Ltd.